WASHINGTON - The House Commerce Committee last week accomplished what Chairman Thomas Bliley called "a miracle", reaching an agreement on medical device labeling that had eluded the Senate's FDA reform efforts.

The agreement enabled the House committee to endorse three FDA reform bills on the heels of the Senate passage of S. 830, the FDA Modernization and Accountability Act of 1997